UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 11.

Avouac, J; Palumbo, K; Tomcik, M; Zerr, P; Dees, C; Horn, A; Maurer, B; Akhmetshina, A; Beyer, C; Sadowski, A; Schneider, H; Shiozawa, S; Distler, O; Schett, G; Allanore, Y; Distler, J H W (2012). Inhibition of AP-1 signaling abrogates TGF-ß mediated activation of fibroblasts and prevents experimental fibrosis. Arthritis and Rheumatism, 64(5):1642-1652.

Beyer, C; Distler, J H W; Allanore, Y; Aringer, M; Avouac, J; Czirják, L; Cutolo, M; Damjanov, N; Del Galdo, F; Fligelstone, K; Guiducci, S; Kowal-Bielecka, O; van Laar, J M; Martucci-Cerinic, M; Müller-Ladner, U; Riemekasten, G; Tarner, I H; Tyndall, A; Kennedy, A T; Valentini, G; Vettori, S; Walker, U A; Denton, C; Distler, O (2011). EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research. Annals of the Rheumatic Diseases, 70(7):1178-1182.

Avouac, J; Fürnrohr, B G; Tomcik, M; Palumbo, K; Zerr, P; Horn, A; Dees, C; Akhmetshina, A; Beyer, C; Distler, O; Schett, G; Allanore, Y; Distler, J H W (2011). Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis. Arthritis and Rheumatism, 63(3):800-809.

Avouac, J; Fransen, J; Walker, U A; Riccieri, V; Smith, V; Muller, C; Miniati, I; Tarner, I H; Randone, S B; Cutolo, M; Allanore, Y; Distler, O; Valentini, G; Czirjak, L; Müller-Ladner, U; Furst, D E; Tyndall, A; Matucci-Cerinic, M (2011). Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Annals of the Rheumatic Diseases, 70(3):476-481.

Denton, C P; Avouac, J; Behrens, F; Furst, D E; Foeldvari, I; Humbert, M; Huscher, D; Kowal-Bielecka, O; Matucci-Cerinic, M; Nash, P; Opitz, C F; Pittrow, D; Rubin, L J; Seibold, J R; Distler, O (2011). Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed. Arthritis Research & Therapy, 13(3):114.

Palumbo, K; Zerr, P; Tomcik, M; Vollath, S; Dees, C; Akhmetshina, A; Avouac, J; Yaniv, M; Distler, O; Schett, G; Distler, J H W (2011). The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosis. Annals of the Rheumatic Diseases, 70(7):1320-1326.

Avouac, J; Kowal-Bielecka, O; Pittrow, D; et al; Distler, O (2010). Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group. Annals of the Rheumatic Diseases, 69(7):1360-1363.

Kowal-Bielecka, O; Avouac, J; Pittrow, D; Huscher, D; Behrens, F; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Strand, V; Furst, D E; Distler, O (2010). Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group. Journal of Rheumatology, 37(1):105-115.

Huscher, D; Pittrow, D; Distler, O; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Kowal-Bielecka, O; Avouac, J; Behrens, F; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Strand, V; Furst, D E; EPOSS-OMERACT Group (2010). Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Clinical and Experimental Rheumatology, 28(2 S 58):S47-52.

Distler, J H W; Allanore, Y; Avouac, J; Giacomelli, R; Guiducci, S; Moritz, F; Akhmetshina, A; Walker, U A; Gabrielli, A; Müller-Ladner, U; Tyndall, A; Matucci-Cerinic, M; Distler, O (2009). EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Annals of the Rheumatic Diseases, 68(2):163-168.

Khanna, D; Distler, O; Avouac, J; Behrens, F; Clements, P J; Denton, C; Foeldvari, I; Giannini, E; Huscher, D; Kowal-Bielecka, O; Lovell, D; Matucci-Cerinic, M; Mayes, M; Merkel, P A; Nash, P; Opitz, C F; Pittrow, D; Rubin, L; Seibold, J R; Steen, V; Strand, C V; Tugwell, P S; Varga, J; Zink, A; Furst, D E (2009). Measures of response in clinical trials of systemic sclerosis: the combined response index for systemic sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS). Journal of Rheumatology, 36(10):2356-2361.

This list was generated on Sat Jul 22 00:14:39 2017 CEST.